Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A D M Vorselaars

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|January 15, 2013
Earlobe sarcoidosisA D M Vorselaars, R G M Keijsers, J C Grutters
Lung|January 30, 2020
Change in Serum Biomarker CA 15-3 as an Early Predictor of Response to Treatment and Survival in Hypersensitivity PneumonitisS A Moll, I A Wiertz, A D M Vorselaars, et al.
Clinical and Experimental Immunology|May 10, 2016
Infliximab therapy balances regulatory T cells, tumour necrosis factor receptor 2 (TNFR2) expression and soluble TNFR2 in sarcoidosisA Verwoerd, D Hijdra, A D M Vorselaars, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|May 6, 2009
Vitamin K deficiency bleeding in cholestatic infants with alpha-1-antitrypsin deficiencyP M van Hasselt, K Kok, A D M Vorselaars, et al.
Brain, Behavior, and Immunity|June 4, 2013
Influence of repeated maximal exercise testing on biomarkers and fatigue in sarcoidosisA W E Braam, S N de Haan, A D M Vorselaars, et al.
Respiratory Research|June 25, 2022
Characterization of the PF-ILD phenotype in patients with advanced pulmonary sarcoidosisM C Schimmelpennink, D B Meek, A D M Vorselaars, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|January 15, 2013
Earlobe sarcoidosisA D M Vorselaars, R G M Keijsers, J C Grutters
Lung|January 30, 2020
Change in Serum Biomarker CA 15-3 as an Early Predictor of Response to Treatment and Survival in Hypersensitivity PneumonitisS A Moll, I A Wiertz, A D M Vorselaars, et al.
Clinical and Experimental Immunology|May 10, 2016
Infliximab therapy balances regulatory T cells, tumour necrosis factor receptor 2 (TNFR2) expression and soluble TNFR2 in sarcoidosisA Verwoerd, D Hijdra, A D M Vorselaars, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|May 6, 2009
Vitamin K deficiency bleeding in cholestatic infants with alpha-1-antitrypsin deficiencyP M van Hasselt, K Kok, A D M Vorselaars, et al.
Brain, Behavior, and Immunity|June 4, 2013
Influence of repeated maximal exercise testing on biomarkers and fatigue in sarcoidosisA W E Braam, S N de Haan, A D M Vorselaars, et al.
Respiratory Research|June 25, 2022
Characterization of the PF-ILD phenotype in patients with advanced pulmonary sarcoidosisM C Schimmelpennink, D B Meek, A D M Vorselaars, et al.
Pageof 1